Induction Of XLF And 53BP1 Expression Is Associated With Temozolomide Resistance In Glioblastoma Cells

INTRODUCTION: Glioblastoma (GBM) is the most commonly diagnosed primary brain tumor in adults. The 14.6 months median survival period of GBM patients is still palliative due to resistance to the first-line chemotherapeutic agent temozolomide (TMZ). METHODS: The cell growth inhibition effect was asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tongxia, Chai, Jie, Chi, Lingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883937/
https://www.ncbi.nlm.nih.gov/pubmed/31819508
http://dx.doi.org/10.2147/OTT.S221025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883937/
https://www.ncbi.nlm.nih.gov/pubmed/31819508
http://dx.doi.org/10.2147/OTT.S221025

Ejemplares similares